Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes

Genes and Development

Volumn 9, Issue 16, 1995, Pages 1953-1964

  McCarthy, Sean A ^a   Samuels, Michael L ^a   Pritchard, Catrin A ^a,c   Abraham, Judith A ^b   McMahon, Martin ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Scios Nova Inc   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

c Jun amino terminal kinase; diphtheria toxin; heparin binding epidermal growth factor; Raf; Ras

Indexed keywords

CELL SURFACE RECEPTOR; DIPHTHERIA TOXIN; EPIDERMAL GROWTH FACTOR; HEPARIN; MESSENGER RNA; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; MOUSE; NONHUMAN; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0029130410     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.16.1953     Document Type: Article

References (80)

1. Aaronson, S.A. 1991. Growth factors and cancer. Science 254: 1146-1153.
2. Abraham, J.A., D. Damm, A. Bajardi, J. Miller, M. Klagsbrun, and R.A. Ezekowitz. 1993. Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun. 190: 125-133.
3. Almendral, J.M., D. Sommer, H. MacDonald-Bravo, J. Burckhardt, J. Perera, and R. Bravo. 1988. Complexity of the early genetic response to growth factors in fibroblasts. Mol. Cell. Biol. 8: 2140-2148.
4. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, I.A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. John Wiley and Sons, New York.
5. Barnard, J.A., R. Graves-Deal, M.R. Pittelkow, R. Du Bois, P. Cook, G.W. Ramsey, P.R. Bishop, L. Damstrup, and R.J. Coffey. 1994. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 269: 22817-22822.
6. Baserga, R. 1994. Oncogenes and the strategy of growth factors. Cell 79: 927-930.
7. Blotnick, S., G.E. Peoples, M.R. Freeman, T.J. Eberlein, and M. Klagsbrun. 1994. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. 91: 2890-2894.
8. Bos, J.L. 1989. Ras oncogenes in human cancer: A review. Cancer Res. 49: 4682-4689.
9. Brunet, A., G. Pages, and J. Pouyssegur. 1994. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9: 3379-3387.
10. Brunner, D., K. Ducker, N. Oellers, E. Hafen, H. Scholz, and C. Klambt. 1994. The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature 370: 386-389.
11. Buzzi, S. and I. Maistrello. 1973. Inhibition of growth of Erlich tumours in Swiss mice by diphtheria toxin. Cancer Res. 33: 2349-2353.
12. Ciardiello, F., N. Kim, N. Hynes, R. Jaggi, S. Redmond, D.S. Liscia, B. Sanfilippo, G. Merlo, R. Callahan, and W. R. Kidwell. 1988. Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene. Mol. Endocrinol. 2: 1202-1216.
13. Ciardiello, F., M.L. McGeady, N. Kim, F. Basolo, N. Hynes, B.C. Langton, H Yokozaki, T. Saeki, J.W. Elliott, and H. Masui. 1990. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Cell Growth Differ. 1: 407-420.
14. Cowley, S., H. Paterson, P. Kemp, and C.J. Marshall. 1994. Activation of MAP Kinase Kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852.
15. De Larco, J.E. and G.J. Todaro. 1978. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. 75: 4001-4005.
16. Derijard, B., M. Hibi, I. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R.J. Davis. 1994. JNK1: A protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell 76: 1025-1037.
17. Dickson, B. and E. Hafen. 1994. Genetics of signal transduction in invertebrates. Curr. Opin. Genet. Dev. 4: 64-70.
18. Dluz, S.M., S. Higashiyama, D. Damm, I.A. Abraham, and M. Klagsbrun. 1993. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 268: 18330-18334.
19. Egan, S.E. and R.A. Weinberg. 1993. The pathway to signal achievement. Nature 365: 781-783.
20. Filmus, J., W. Shi, and T. Spencer. 1993. Role of transforming growth factor alpha in the transformation of ras-transfected rat intestinal epithelial cells. Oncogene 8: 1017-1022.
21. Gallego, C., S.K. Gupta, L.E. Heasley, N.X. Qian, and G.L. Johnson. 1992. Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells. Proc. Natl. Acad. Sci. 89: 7355-7359.
22. Gupta, S., D. Campbell, B. Derijard, and R.J. Davis. 1995. Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 267: 389-393.
23. Gupta, S.K., C. Gallego, G.L. Johnson, and L.E. Heasley. 1992. MAP kinase is constitutively activated in gip2 and src transformed ratla fibroblasts. J. Biol. Chem. 267: 7987-7990.
24. Hambleton, J., M. McMahon, and A.L. DeFranco. 1995. Activation of Raf-1 and mitogen activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J. Exp. Med. 182: 147-154.
25. Hashimoto, K., S. Higashiyama, H. Asada, E. Hashimura, T. Kobayashi, K. Sudo, T. Nakagawa, D. Damm, K. Yoshikawa, and N. Taniguchi. 1994. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 269: 20060-20066.
26. Heidaran, M.A., T.P. Fleming, D.P. Bottaro, G.I. Bell, P.P. Di Fiore, and S.A. Aaronson. 1990. Transformation of NIH3T3 fibroblasts by an expression vector for the human Epidermal Growth Factor precursor. Oncogene 5: 1265-1270.
27. Herschman, H.R. 1991. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60: 281-319.
28. Herskowitz, I. 1995. MAP kinase pathways in yeast: For mating and more. Cell 80: 187-197.
29. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes & Dev. 7: 2135-2148.
30. Higashiyama, S., J.A. Abraham, J. Miller, J.C. Fiddes, and M. Klagsbrun. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936-939.
31. Higashiyama, S., K. Lau, G.E. Besner, J.A. Abraham, and M. Klagsbrun. 1992. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 267: 6205-6212.
32. Higashiyama, S., J.A. Abraham, and M. Klagsbrun. 1993. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122: 933-940.
33. Hill, C.S. and R. Treisman. 1995. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80: 199-211.
34. Hill, C.S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73: 395-406.
35. Hunter, T. and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70: 375-387.
36. Iglewski, B.H. and M.B. Rittenberg. 1974. Selective toxicity of diphtheria toxin for malignant cells. Proc. Natl. Acad. Sci. 71: 2707-2710.
37. Iglewski, B.H., M.B. Rittenberg, and W.J. Iglewski. 1975. Preferential inhibition of growth and protein synthesis in Rous sarcoma virus transformed cells by diphtheria toxin. Virology 65: 272-275.
38. Inui, Y., S. Higashiyama, S. Kawata, S. Tamura, J. Miyagawa, N. Taniguchi, and Y. Matsuzawa. 1994. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma. Gastroenterology 107: 1799-1804.
39. Ito, N., S. Kawata, S. Tamura, S. Kiso, H. Tsushima, D. Damm, I.A. Abraham, S. Higashiyama, N. Taniguchi, and Y. Matsuzawa. 1994. Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. Biochem. Biophys. Res. Commun. 198: 25-31.
40. Iwamoto, R., S. Higashiyama, T. Mitamura, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1994. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 13: 2322-2330.
41. Karin, M. 1994. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6: 415-424.
42. Kobrin, M.S., H. Funatomi, H. Friess, M.W. Buchler, P. Stathis, and M. Korc. 1994. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 202: 1705-1709.
43. Kyriakis, J.M., P. Banerjee, E. Nikolakaki, T. Dai, E.A. Rubie, M.F. Ahmad, J. Avruch, and J.R. Woodgett. 1994. The stress activated protein kinase subfamily of c-jun kinases. Nature 369: 156-160.
44. Lange-Carter, C.A. and G.L. Johnson. 1994. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265: 1458-1461.
45. Lange-Carter, C.A., C.M. Pleiman, A.M. Gardner, K.J. Blumer, and G.L. Johnson. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260: 315-319.
46. Liang, P. and A. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971.
47. Liang, P., L. Averboukh, and A.B. Pardee. 1993. Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimization. Nucleic Acids Res. 21: 3269-3275.
48. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-394.
49. Marshall, C.J. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4: 82-89.
50. _. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
51. McCarthy, S.A. and R.B. Bicknell. 1992. Responses of pertussis toxin-treated microvascular endothelial cells to transforming growth factor beta. J. Biol. Chem. 267: 21617-21622.
52. Middlebrook, J.L. and R.B. Dorland. 1984. Bacterial toxins: Cellular mechanisms of action. Microbiol. Rev. 48: 199-221.
53. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R.J. Davis, G.L. Johnson, and M. Karin. 1994a. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723.
54. Minden, A., A. Lin, T. Smeal, B. Derijard, M. Cobb, R. Davis, and M. Karin. 1994b. c-jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen activated protein kinases. Mol. Cell. Biol. 14: 6683-6688.
55. Morita, T., M. Yoshizumi, H. Kurihara, K. Maemura, R. Nagai, and Y. Yazaki. 1993. Shear stress increases heparin-binding epidermal growth factor-like growth factor mRNA levels in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 197: 256-262.
56. Morrison, D.K. 1990. The Raf-1 kinase as a transducer of mitogenic signals. Cancer Cells 2: 377-382.
57. Naglich, J.G., J.E. Metherall, D.W. Russell, and L. Eidels. 1992a. Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 69: 1051-1061.
58. Naglich, J.G., J.M. Rolf, and L. Eidels. 1992b. Expression of functional diphtheria toxin receptors on highly sensitive mouse cells that specifically bind radioiodinated toxin. Proc. Natl. Acad. Sci. 89: 2170-2174.
59. Nakano, T., E.W. Raines, J.A. Abraham, M. Klagsbrun, and R. Ross. 1994. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci. 91: 1069-1073.
60. Nakano, T., E.W. Raines, J.A. Abraham, F. Wenzel, S. Higashiyama, M. Klagsbrun, and R. Ross. 1993. Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. J. Biol. Chem. 268: 22941-22947.
61. Nishida, E. and Y. Gotoh. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18: 128-131.
62. O'Farrell, P.H. 1975. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250: 4007-4021.
63. O'Neill, E.M., I. Rebay, R. Tijan, and G.M. Rubin. 1994. The activities of two ets-related transcription factors required for Drosophila eye development are modulated by the ras/ MAPK pathway. Cell 78: 137-147.
64. Pappenheimer, A.M. 1977. Diphtheria toxin. Annu. Rev. Biochem. 46: 69-94.
65. Perrella, M.A., T. Maki, S. Prasad, D. Pimentai, K. Singh, N. Takahashi, M. Yoshizumi, A. Alali, S. Higashiyama, and R.A. Kelly. 1994. Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J. Biol. Chem. 269: 27045-27050.
66. Raab, G., S. Higashiyama, S. Hetelekidis, J.A. Abraham, D. Damm, M. Ono, and M. Klagsbrun. 1994. Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem. Biophys. Res. Commun. 204: 592-597.
67. Rapp, U.R. 1991. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6: 495-500.
68. Rebay, I. and G.M. Rubin. 1995. Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell 81: 857-866.
69. Russell, M., C.A. Lange-Carter, and G.L. Johnson. 1995. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J. Biol. Chem. 270: 11757-11760.
70. Samuels, M.L., M.J. Weber, J.M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13: 6241-6252.
71. Samuels, M.L. and M. McMahon. 1994. Inhibition of PDGF and EGF-mediated mitogenesis and signaling in 3T3 cells expressing ΔRaf-1:ER, an estradiol-regulated form of Raf-1. Mol. Cell. Biol. 14: 7855-7866.
72. Sanchez, I., R.T. Hughes, B.J. Mayer, K. Yee, J.R. Woodgett, J. Avruch, J.M. Kyriakis, and L.I. Zon. 1994. Role of SAPK/ ERK kinase-1 in the stress activated pathway regulating transcription factor c-jun. Nature 372: 794-798.
73. Stern, D.F., D.L. Hare, M.A. Cecchini, and R.A. Weinberg. 1987. Construction of a novel oncogene based on synthetic sequences encoding Epidermal Growth Factor. Science 235: 321-324.
74. Sternberg, P.W., A. Golden, and M. Han. 1993. Role of a raf proto-oncogene during Caenorhabditis elegans vulval development. Phil. Trans. R. Soc. Lond. 340: 259-265.
75. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during co-stimulation of T lymphocytes. Cell 77: 727-736.
76. Tan, M.S., Y.J. Lee, S.J. Shin, and J.H. Tsai. 1994. Regulation of heparin binding-epidermal growth factor like growth factor gene expression by LDL and oxidized-LDL in rat mesangial cells. Biochem. Biophys. Res. Commun. 202: 1001-1008.
77. Taylor, A. and W.J. Iglewski. 1979. Intoxication of normal and virus transformed cells by diphtheria toxin. Virology 96: 177-185.
78. Temizer, D.H., M. Yoshizumi, M.A. Perrella, E.E. Susanni, T. Quertermous, and M.E. Lee. 1992. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 267: 24892-24896.
79. Yan, M., T. Dai, J.C. Deak, J.M. Kyriakis, L.I. Zon, J.R. Woodgett, and D.J. Templeton. 1994. Activation of stress activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372: 798-800.
80. Yoshizumi, M., S. Kourembanas, D.H. Temizer, R.P. Cambria, T. Quertermous, and M.E. Lee. 1992. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J. Biol. Chem. 267: 9467-9469.